Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015
- Author:
Chang Dong YEO
1
;
Myoung Kyu LEE
;
Seung Hyeun LEE
;
Eun Young KIM
;
Ik Jae LEE
;
Heae Surng PARK
;
Yoon Soo CHANG
Author Information
- Publication Type:Review
- From:Tuberculosis and Respiratory Diseases 2018;81(1):19-28
- CountryRepublic of Korea
- Language:English
- Abstract: Cancer is the leading cause of death in the Republic of Korea and cancer death accounts for 27.8% of the total deaths, which is not only a social issue but also a concern for the public. Among the cancer death rates, lung cancer mortality account for 34 deaths per 100,000 populations, making it the number one cancer death rate. In a preliminary report on cancer death in 2012, the lung cancer mortality ratio showed the regional variation indicating that there were differences in the qualitative level and the structure among the medical care benefit agency and in the assessment of the treatment process. Therefore, the Health Insurance Review and Assessment Service (HIRA) had begun evaluation of the assessment of lung cancer treatment since 2014 to improve the quality of lung cancer care through evaluation and feeds back the results of lung cancer care process. In this report, authors described the current Indicators for the lung cancer adequacy assessment proposed by HIRA and results of the evaluation reported in 2017.
